Stay updated with breaking news from Morphotek Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON, May 16 /PRNewswire/ -- Eisai Europe Ltd announced today that results from 9 clinical data abstracts about compounds in the company's oncology pipeline, product portfolio and preclinical oncology research have been accepted for presentation at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO), taking place in Chicag
(CSE: FOG.X) (OTCB: FOGCF) (FRA: MUU3) (the " Company" or " FogChain") is pleased to announce, further to its news release dated January 13, 2021, the Company has entered into a merger agreement and plan of reorganization (the " Definitive Agreement") with Avisa Pharma Inc. (" Avisa") and FogChain USA Inc., a wholly-owned subsidiary of FogChain, dated February 1, 2021, in respect of a statutory merger under the Delaware General Corporation Law pursuant to which the Company has agreed to acquire all of the issued and outstanding shares in the capital of Avisa (the " Avisa Shares"), a private...